CLINICAL TRIAL OF KADUKKAI ENNAI FOR SUZHI KANAM IN CHILDREN

CLINICAL EVALUATION OF KADUKKAI ENNAI(INTERNAL)FOR SUZHI KANAM(PHARYNGITIS)IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014127

Enrollment

Registered

2018-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified Health Condition 2: null- baby with the complaints of sore throat, cough,dysphagia,abdominal discomfort,poor appetite,fever.

Interventions

Intervention1: Kadukkai ennai (internal): Kadukkai ennai is a poly herbal formulation with the dosage of 1.6 ml only at morning for 7 days. Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.sore throat. 2. cough. 3. abdominal discomfort. 4. fever. 5. dysphagia. 6. poor appetite.

Exclusion criteria

Exclusion criteria: 1. allergic rhinitis. 2. pneumonia. 3. severe asthma. 4.Stridor

Design outcomes

Primary

Measure	Time frame
Efficacy of the trail drug is measured by scoring system and improvement in the clinical condition is assuredTimepoint: 1 to 7 days	—

Secondary

Measure	Time frame
reduction in the recurrence of the disease and improvement in the quality of life of childrenTimepoint: 1 to 7 days	—

Countries

India

Contacts

Public ContactDr M Meenakshi sundaram

National institute of siddha

drmmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026